enGene Therapeutics's three largest insider shareholders as of September 29, 2026 are Growth Sponsor Feac I B.V. Forbion (TenPercentOwner, 3.77Mn shares), De Solidarite Des Travailleurs Du Quebec Fonds (TenPercentOwner, 3.04Mn shares), Growth Opportunities Fund I Cooperatief U.A. Forbion (TenPercentOwner, 3.03Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Growth Sponsor Feac I B.V. Forbion | TenPercentOwner | 0 | 3,765,932 | 3,765,932 | 32.9% | 02 Nov, 2023 |
| 2 | De Solidarite Des Travailleurs Du Quebec Fonds | TenPercentOwner | 3,036,153 | 0 | 3,036,153 | 26.5% | 22 Apr, 2024 |
| 3 | Growth Opportunities Fund I Cooperatief U.A. Forbion | TenPercentOwner | 3,032,430 | 0 | 3,032,430 | 26.5% | 01 Nov, 2024 |
| 4 | Capital Investment Management Inc. Lumira | TenPercentOwner | 0 | 1,232,502 | 1,232,502 | 10.8% | 21 Feb, 2024 |
| 5 | Gerald A Brunk | Director, TenPercentOwner | 0 | 238,851 | 238,851 | 2.1% | 21 Feb, 2024 |
| 6 | Anthony Tzeyew Cheung | Chief Technology Officer | 102,873 | 0 | 102,873 | 0.9% | 20 Mar, 2024 |
| 7 | Richard M Glickman | Director | 24,675 | 0 | 24,675 | 0.2% | 29 May, 2024 |
| 8 | Ronald Harold Wilfred Cooper | Chief Executive Officer | 10,000 | 0 | 10,000 | 0.1% | 01 Oct, 2024 |
| 9 | William Grossman | Interim Chief Medical Officer | 5,102 | 0 | 5,102 | 0.0% | 24 Sep, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 22 Sep, 2026 | William Grossman | Interim Chief Medical Officer | Acquired P | 5,102 | $1.97 | $10.05K | 5,102 | Direct |
| 16 Jun, 2026 | Richard M Glickman | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 16 Jun, 2026 | Wouter Joustra | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 16 Jun, 2026 | William Grossman | Interim Chief Medical Officer | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 16 Jun, 2026 | Gerald A Brunk | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 16 Jun, 2026 | Paul J Hastings | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 16 Jun, 2026 | Michael Thomas Heffernan | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 16 Jun, 2026 | Lota S. Zoth | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 16 Jun, 2026 | Philip Astley-Sparke | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 16 Jun, 2026 | William Grossman | Interim Chief Medical Officer | Acquired A | 200,000 | $0.00 | $0 | 200,000 | Direct |
| 30 Jan, 2026 | Anthony Tzeyew Cheung | Chief Scientific Officer | Acquired A | 195,000 | $0.00 | $0 | 195,000 | Direct |
| 30 Jan, 2026 | Lee Giguere | Chief Legal Ofc. And Corp Secy | Acquired A | 195,000 | $0.00 | $0 | 195,000 | Direct |
| 30 Jan, 2026 | Jill Buck | Chief Development Officer | Acquired A | 195,000 | $0.00 | $0 | 195,000 | Direct |
| 30 Jan, 2026 | Alexander Julian Nichols | Chief Strategy Ops. Ofc | Acquired A | 195,000 | $0.00 | $0 | 195,000 | Direct |
| 30 Jan, 2026 | Ronald Harold Wilfred Cooper | Ceo President | Acquired A | 801,000 | $0.00 | $0 | 801,000 | Direct |
| 30 Jan, 2026 | Matthew Ross Boyd | Chief Regulatory Officer | Acquired A | 195,000 | $0.00 | $0 | 195,000 | Direct |
| 30 Jan, 2026 | D. Ryan Daws | Chief Financial Officer | Acquired A | 220,000 | $0.00 | $0 | 220,000 | Direct |
| 30 Jan, 2026 | Joan Connolly | Chief Technology Officer | Acquired A | 195,000 | $0.00 | $0 | 195,000 | Direct |
| 30 Sep, 2025 | Hussein Sweiti | Chief Medical Officer | Acquired A | 600,000 | $0.00 | $0 | 600,000 | Direct |
| 08 Jul, 2025 | Matthew Ross Boyd | Chief Regulatory Officer | Acquired A | 100,000 | $0.00 | $0 | 100,000 | Direct |